$PMCB announced that it has filed a U.S. patent application with the United States Patent and Trademark Office to protect its therapy to treat cancerous tumors, including the therapy that will be used in its upcoming clinical trial in locally advanced, non-metastatic, inoperable pancreatic cancer. https://finance.yahoo.com/news/pharmacyte-bio...00028.html